Related Experiment Video

Updated: Mar 14, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Cancer/testis antigens as molecular drug targets using network pharmacology

Anuj Kumar1, Drista Sharma2, M L Aggarwal3

  • 1Shriram Institute for Industrial Research, 19, University Road Delhi, Delhi, 110 007, India. anuj.ahar@gmail.com.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|October 7, 2016
PubMed

Insights

Computational network analysis identified 30 potential anticancer drug targets from cancer/testis antigens. These targets could selectively harm cancer cells, offering a promising avenue for new cancer therapies.

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Current chemotherapies exhibit limited efficacy and significant side effects.
  • Discovering novel drug targets is crucial for effective cancer treatment strategies.
  • Cancer/testis antigens play a critical role in cancer cell progression.

Purpose of the Study:

  • To perform a computational network analysis of cancer/testis antigens (CT antigens).
  • To identify and assess CT antigens as potential drug targets for cancer therapy.
  • To predict novel protein targets that are essential for cancer cell survival.

Main Methods:

  • Investigated the protein interaction network of 700 human CT antigens.
  • Analyzed network topology using parameters like betweenness centrality and cluster coefficient.
  • Identified key hub proteins and predicted potential drug targets based on network analysis.

Main Results:

  • The CT antigen network comprised eight independent components.
  • Identified four major and two minor hub proteins critical for information flow.
  • Predicted 30 potential drug targets with significant roles in cancer progression.

Conclusions:

  • The identified CT antigen network analysis provides a list of candidate proteins for targeted cancer therapy.
  • These potential targets are predicted to be detrimental to cancer cells while sparing normal cells.
  • The findings serve as a foundation for experimental validation and the discovery of new anticancer drugs.
Keywords:
Anticancer targetsCancerCancer/testis antigensProtein interaction network

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61